Gold nanoparticles as contrast agents in X-ray imaging and computed tomography

Lisa E. Cole, Ryan D. Ross, Jennifer M. Tilley, Tracy Vargo-Gogola, Ryan K. Roeder

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Computed tomography enables 3D anatomic imaging at a high spatial resolution, but requires delivery of an X-ray contrast agent to distinguish tissues with similar or low X-ray attenuation. Gold nanoparticles (AuNPs) have gained recent attention as an X-ray contrast agent due to exhibiting a high X-ray attenuation, nontoxicity and facile synthesis and surface functionalization for colloidal stability and targeted delivery. Potential diagnostic applications include blood pool imaging, passive targeting and active targeting, where actively targeted AuNPs could enable molecular imaging by computed tomography. This article summarizes the current state of knowledge for AuNP X-ray contrast agents within a paradigm of key structure-property-function relationships in order to provide guidance for the design of AuNP contrast agents to meet the necessary functional requirements in a particular application. Functional requirements include delivery to the site of interest (e.g., blood, tumors or microcalcifications), nontoxicity during delivery and clearance, targeting or localization at the site of interest and contrast enhancement for the site of interest compared with surrounding tissues. Design is achieved by strategically controlling structural characteristics (composition, mass concentration, size, shape and surface functionalization) for optimized properties and functional performance. Examples from the literature are used to highlight current design trade-offs that exist between the different functional requirements.

Original languageEnglish (US)
Pages (from-to)321-341
Number of pages21
JournalNanomedicine
Volume10
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

X Ray Computed Tomography
gold
Gold
Nanoparticles
Contrast Media
tomography
Tomography
X-Rays
Imaging techniques
X rays
targeting
ownership structure
Blood
blood
Tissue
diagnostic
Molecular imaging
Calcinosis
Molecular Imaging
paradigm

Keywords

  • computed tomography
  • contrast agent
  • delivery
  • gold nanoparticles
  • surface functionalization
  • targeting
  • X-ray imaging

ASJC Scopus subject areas

  • Materials Science(all)
  • Bioengineering
  • Biomedical Engineering
  • Medicine (miscellaneous)
  • Development
  • Medicine(all)

Cite this

Gold nanoparticles as contrast agents in X-ray imaging and computed tomography. / Cole, Lisa E.; Ross, Ryan D.; Tilley, Jennifer M.; Vargo-Gogola, Tracy; Roeder, Ryan K.

In: Nanomedicine, Vol. 10, No. 2, 01.01.2015, p. 321-341.

Research output: Contribution to journalArticle

Cole, Lisa E. ; Ross, Ryan D. ; Tilley, Jennifer M. ; Vargo-Gogola, Tracy ; Roeder, Ryan K. / Gold nanoparticles as contrast agents in X-ray imaging and computed tomography. In: Nanomedicine. 2015 ; Vol. 10, No. 2. pp. 321-341.
@article{acbca13dfb5d4642b14a6d9afeb4161a,
title = "Gold nanoparticles as contrast agents in X-ray imaging and computed tomography",
abstract = "Computed tomography enables 3D anatomic imaging at a high spatial resolution, but requires delivery of an X-ray contrast agent to distinguish tissues with similar or low X-ray attenuation. Gold nanoparticles (AuNPs) have gained recent attention as an X-ray contrast agent due to exhibiting a high X-ray attenuation, nontoxicity and facile synthesis and surface functionalization for colloidal stability and targeted delivery. Potential diagnostic applications include blood pool imaging, passive targeting and active targeting, where actively targeted AuNPs could enable molecular imaging by computed tomography. This article summarizes the current state of knowledge for AuNP X-ray contrast agents within a paradigm of key structure-property-function relationships in order to provide guidance for the design of AuNP contrast agents to meet the necessary functional requirements in a particular application. Functional requirements include delivery to the site of interest (e.g., blood, tumors or microcalcifications), nontoxicity during delivery and clearance, targeting or localization at the site of interest and contrast enhancement for the site of interest compared with surrounding tissues. Design is achieved by strategically controlling structural characteristics (composition, mass concentration, size, shape and surface functionalization) for optimized properties and functional performance. Examples from the literature are used to highlight current design trade-offs that exist between the different functional requirements.",
keywords = "computed tomography, contrast agent, delivery, gold nanoparticles, surface functionalization, targeting, X-ray imaging",
author = "Cole, {Lisa E.} and Ross, {Ryan D.} and Tilley, {Jennifer M.} and Tracy Vargo-Gogola and Roeder, {Ryan K.}",
year = "2015",
month = "1",
day = "1",
doi = "10.2217/nnm.14.171",
language = "English (US)",
volume = "10",
pages = "321--341",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Gold nanoparticles as contrast agents in X-ray imaging and computed tomography

AU - Cole, Lisa E.

AU - Ross, Ryan D.

AU - Tilley, Jennifer M.

AU - Vargo-Gogola, Tracy

AU - Roeder, Ryan K.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Computed tomography enables 3D anatomic imaging at a high spatial resolution, but requires delivery of an X-ray contrast agent to distinguish tissues with similar or low X-ray attenuation. Gold nanoparticles (AuNPs) have gained recent attention as an X-ray contrast agent due to exhibiting a high X-ray attenuation, nontoxicity and facile synthesis and surface functionalization for colloidal stability and targeted delivery. Potential diagnostic applications include blood pool imaging, passive targeting and active targeting, where actively targeted AuNPs could enable molecular imaging by computed tomography. This article summarizes the current state of knowledge for AuNP X-ray contrast agents within a paradigm of key structure-property-function relationships in order to provide guidance for the design of AuNP contrast agents to meet the necessary functional requirements in a particular application. Functional requirements include delivery to the site of interest (e.g., blood, tumors or microcalcifications), nontoxicity during delivery and clearance, targeting or localization at the site of interest and contrast enhancement for the site of interest compared with surrounding tissues. Design is achieved by strategically controlling structural characteristics (composition, mass concentration, size, shape and surface functionalization) for optimized properties and functional performance. Examples from the literature are used to highlight current design trade-offs that exist between the different functional requirements.

AB - Computed tomography enables 3D anatomic imaging at a high spatial resolution, but requires delivery of an X-ray contrast agent to distinguish tissues with similar or low X-ray attenuation. Gold nanoparticles (AuNPs) have gained recent attention as an X-ray contrast agent due to exhibiting a high X-ray attenuation, nontoxicity and facile synthesis and surface functionalization for colloidal stability and targeted delivery. Potential diagnostic applications include blood pool imaging, passive targeting and active targeting, where actively targeted AuNPs could enable molecular imaging by computed tomography. This article summarizes the current state of knowledge for AuNP X-ray contrast agents within a paradigm of key structure-property-function relationships in order to provide guidance for the design of AuNP contrast agents to meet the necessary functional requirements in a particular application. Functional requirements include delivery to the site of interest (e.g., blood, tumors or microcalcifications), nontoxicity during delivery and clearance, targeting or localization at the site of interest and contrast enhancement for the site of interest compared with surrounding tissues. Design is achieved by strategically controlling structural characteristics (composition, mass concentration, size, shape and surface functionalization) for optimized properties and functional performance. Examples from the literature are used to highlight current design trade-offs that exist between the different functional requirements.

KW - computed tomography

KW - contrast agent

KW - delivery

KW - gold nanoparticles

KW - surface functionalization

KW - targeting

KW - X-ray imaging

UR - http://www.scopus.com/inward/record.url?scp=84921496485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921496485&partnerID=8YFLogxK

U2 - 10.2217/nnm.14.171

DO - 10.2217/nnm.14.171

M3 - Article

C2 - 25600973

AN - SCOPUS:84921496485

VL - 10

SP - 321

EP - 341

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 2

ER -